ArticleJournal of hepatocellular carcinoma2026
Combination of Traditional Chinese Medicine and Transarterial Chemoembolization for Hepatocellular Carcinoma: A Bibliometric Analysis.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Increasingly, studies have indicated that traditional Chinese medicine (TCM) plus transarterial chemoembolization (TACE) has better efficacy and lower side effects for hepatocellular carcinoma (HCC) patients. However, there is a notable absence of visual evidence within the field of TCM plus TACE in HCC. Therefore, this study aimed to utilize bibliometric technology to visualize the research knowledge structure and identify emerging hotspots of TCM combined with TACE in HCC. Methods: The publications relating to TCM plus TACE on HCC published up to October 17, 2025 were obtained from the Web of Science Core Collection (WoSCC) database. Bibliometric analysis was conducted using VOSviewer, CiteSpace, and the R-bibliometrix. Results: A total of 399 publications were included in the analysis. The number of related publications and citations has steadily increased. China has established itself as the leading contributor to the literature in this field, with significant contributions also emanating from Japan and the USA. Among institutional contributors, the Sun Yat Sen University has demonstrated particular prominence in publication output. Conclusion: This work serves as a framework for understanding the evolution and frontiers of the field, thereby paving the way for further scientific and clinical advances in the application of TCM with TACE for HCC. Consequently, more HCC patients can benefit from the methods of TCM plus TACE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.